Related Experiment Videos
Intracerebral haemorrhage after thrombolytic therapy for acute myocardial infarction
Insights
Thrombolytic therapy for acute myocardial infarction can cause intracerebral hemorrhage. Confusional state is a common symptom, with older males at higher risk. Early recognition and management are crucial.
Area of Science:
- Cardiology
- Neurology
- Pharmacology
Background:
- Thrombolytic therapy is a critical treatment for acute myocardial infarction (AMI).
- Intracerebral hemorrhage (ICH) is a known but infrequent complication of thrombolytic treatment.
- Understanding risk factors and presentation is vital for patient safety.
Observation:
- Seven cases of ICH were identified in 710 patients receiving thrombolytic therapy for AMI.
- The most frequent initial symptom observed was a confusional state.
- Older age and male sex were identified as risk factors for ICH.
Findings:
- The incidence of ICH in this cohort was approximately 1%.
- Confusional state emerged as the most common presenting neurological feature.
- Advanced age and male gender correlated with a higher likelihood of cerebral bleeding.
Implications:
- This study highlights the importance of vigilant monitoring for neurological complications post-thrombolysis.
- Early detection of symptoms like confusion can facilitate prompt intervention.
- Further research into the role of adjunctive therapies, such as intravenous heparin, in mitigating ICH risk is warranted.
Abstract:
Seven cases of intracerebral haemorrhage were identified following the use of thrombolytic therapy in a total of 710 patients with acute myocardial infarction. Each case was reviewed in detail with particular attention to the presenting symptoms. A confusional state was the commonest initial feature. Increased age and male sex were associated with increased risk of cerebral bleed. The possible role of intravenous heparin in increasing risk and the management of affected cases is discussed. Early recognition and action is emphasized.